Hemostemix (@hemostemix) (#TSXV: $HEM | #OTC: $HMTXF) Announces Dr. Mary Argent-Katwala as Clinical Trial Manager [https://t.co/ZVDrPHWDB0]

#investing #stocks #stockmarket #trading #investors #capitalmarkets #business #investments #news #healthcare  #stemcells #stemcelltherapy https://t.co/8jGyENYE8P